XRHealth acquired Heidelberg, Germany-based living brain, the therapeutic-technology company announced Monday, November 2, adding virtual-reality tools that let patients practice everyday tasks during cognitive rehabilitation. The announcement did not disclose a purchase price or other financial terms.
The acquisition announcement says XRHealth will incorporate living brain’s teora mind software, which uses settings such as kitchens, gardens and stores to support cognitive training. The product is designed to let patients rehearse activities they may need to perform outside a therapy room, with exercises that therapists can adjust to individual needs.
The acquired portfolio also includes teora platform, a web application for patient profiles and progress tracking; teora body, which supports upper-extremity motor rehabilitation; and teora Supervisor, which lets a therapist view the contents of a patient’s VR headset on a tablet during a session.
Teora mind contains 25 everyday-life scenarios with adjustable difficulty, according to the release. Living brain’s product information describes tasks such as making coffee, sorting groceries and planning the steps needed to grow plants. The aim is to connect cognitive exercises to daily routines, rather than presenting only abstract memory or attention tasks.
XRHealth Chief Executive Eran Orr said the deal expands the company’s digital-therapeutics platform and its ability to offer cognitive rehabilitation beyond traditional clinical settings. Living brain founder and CEO Julian Specht said joining XRHealth could extend the reach of its approach. Those statements describe the companies’ plans, not measured results of the acquisition.
The companies say teora mind has been evaluated at seven clinical sites in Germany and cite a randomized neurorehabilitation study published in 2023. The acquisition release does not announce new trial results. Claims about improvements in cognitive performance refer to earlier research, and the transaction itself does not establish that every patient will benefit or that the software replaces clinical care.
The release describes teora mind as an MDR Class IIa-certified medical device in Europe. That European status should not be confused with a new U.S. FDA approval arising from this acquisition. The announcement did not disclose a new U.S. regulatory decision, a rollout schedule for the acquired products or a change in insurance coverage.
Living brain was founded in 2019 and develops immersive rehabilitation tools that can be used in clinical settings and at home with therapist oversight, according to the company. For XRHealth, the deal adds a cognitive-training product suite and its monitoring tools. The next step is incorporation into the wider platform, rather than a newly proven treatment effect disclosed Monday.
JBizNews Desk | Boston
© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.
